Gregory D. Perry
2014 - Eleven Biotherapeutics
In 2014, Gregory D. Perry earned a total compensation of $453.9K as Chief Financial and Business Officer at Eleven Biotherapeutics, a 50% decrease compared to previous year.
Compensation breakdown
| Bonus | $89,851 |
|---|---|
| Salary | $340,000 |
| Other | $24,000 |
| Total | $453,851 |
Perry received $340K in salary, accounting for 75% of the total pay in 2014.
Perry also received $89.9K in bonus and $24K in other compensation.
Rankings
In 2014, Gregory D. Perry's compensation ranked 10,596th out of 13,032 executives tracked by ExecPay. In other words, Perry earned more than 18.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,596 out of 13,032 | 19th |
Division Manufacturing | 4,036 out of 4,966 | 19th |
Major group Chemicals And Allied Products | 1,387 out of 1,686 | 18th |
Industry group Drugs | 1,111 out of 1,365 | 19th |
Industry Pharmaceutical Preparations | 845 out of 1,043 | 19th |
Source: SEC filing on May 7, 2015.
Perry's colleagues
We found two more compensation records of executives who worked with Gregory D. Perry at Eleven Biotherapeutics in 2014.